Stock Analysis

Sentiment Still Eluding Xinjiang Qingsong Building Materials and Chemicals(Group)Co,Ltd. (SHSE:600425)

SHSE:600425
Source: Shutterstock

With a price-to-earnings (or "P/E") ratio of 12x Xinjiang Qingsong Building Materials and Chemicals(Group)Co,Ltd. (SHSE:600425) may be sending very bullish signals at the moment, given that almost half of all companies in China have P/E ratios greater than 32x and even P/E's higher than 59x are not unusual. However, the P/E might be quite low for a reason and it requires further investigation to determine if it's justified.

Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd could be doing better as its earnings have been going backwards lately while most other companies have been seeing positive earnings growth. The P/E is probably low because investors think this poor earnings performance isn't going to get any better. If you still like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.

See our latest analysis for Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd

pe-multiple-vs-industry
SHSE:600425 Price to Earnings Ratio vs Industry June 3rd 2024
Keen to find out how analysts think Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd's future stacks up against the industry? In that case, our free report is a great place to start.

How Is Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd's Growth Trending?

There's an inherent assumption that a company should far underperform the market for P/E ratios like Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd's to be considered reasonable.

Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 4.4%. However, a few very strong years before that means that it was still able to grow EPS by an impressive 44% in total over the last three years. Accordingly, while they would have preferred to keep the run going, shareholders would probably welcome the medium-term rates of earnings growth.

Turning to the outlook, the next three years should generate growth of 23% per annum as estimated by the dual analysts watching the company. With the market predicted to deliver 25% growth per annum, the company is positioned for a comparable earnings result.

With this information, we find it odd that Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd is trading at a P/E lower than the market. It may be that most investors are not convinced the company can achieve future growth expectations.

The Final Word

It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

Our examination of Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd's analyst forecasts revealed that its market-matching earnings outlook isn't contributing to its P/E as much as we would have predicted. When we see an average earnings outlook with market-like growth, we assume potential risks are what might be placing pressure on the P/E ratio. At least the risk of a price drop looks to be subdued, but investors seem to think future earnings could see some volatility.

You should always think about risks. Case in point, we've spotted 1 warning sign for Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd you should be aware of.

You might be able to find a better investment than Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd. If you want a selection of possible candidates, check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

Valuation is complex, but we're helping make it simple.

Find out whether Xinjiang Qingsong Building Materials and Chemicals(Group)CoLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.